Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shibani M Kudchadkar"'
Autor:
Stefan L. Zimmerman, Sagar Goyal, Hulya Yalcin, M. Roselle Abraham, Effrosyni Kontari, Shibani M. Kudchadkar, Celia P. Corona-Villalobos, Dai Yin Lu, Gabriela V. Greenland, Ioannis Ventoulis, Styliani Vakrou, Hongyun Liu, Theodore P. Abraham
Publikováno v:
American Heart Journal. 219:58-69
Background It is unknown whether sex-specific differences in mortality observed in HCM are due to older age of women at presentation, or whether women have greater degree of LV myopathy than men. Methods We retrospectively compared clinical/imaging c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95c0cf5b1e6f1c8c243d8f03eb9b061
https://doi.org/10.1016/j.ahj.2019.10.004
https://doi.org/10.1016/j.ahj.2019.10.004
Autor:
Alicia S Eustes, Jagadish Swamy, melissa jensen, Katina M Wilson, Shibani M Kudchadkar, Usha Perepu, Francis J Miller, Steven R Lentz, Sanjana Dayal
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 41
Background: Severe COVID-19 leads to inflammation and coagulopathy with progression to multiple organ failure. Several prothrombotic mechanisms have been proposed, including NETosis with release of citrullinated histones, platelet hyperactivation, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dbaf5a6fd7dc77b12541f240c67ba9b
https://doi.org/10.1161/atvb.41.suppl_1.mp03
https://doi.org/10.1161/atvb.41.suppl_1.mp03
Autor:
Nestor Vasquez, Gabriela V. Greenland, M. Roselle Abraham, Sanjay Sivalokanathan, Ketty Dolores-Cerna, Dai Yin Lu, Shibani M. Kudchadkar, Saman Nazarian, Tarek Zghaib, Effrosyni Kontari, Jeffrey E. Olgin, Rob J. van der Geest, Theodore P. Abraham, Ihab R. Kamel, Stefan L. Zimmerman
Publikováno v:
JACC: Clinical Electrophysiology. 5:364-375
OBJECTIVES This study hypothesized that paroxysmal atrial fibrillation (PAF) reflects the presence of a more severe cardiac hypertrophic cardiomyopathy (HCM) phenotype.BACKGROUND HCM is characterized by myocyte hypertrophy, fibrosis, and a high preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c23afeec71f813647d0cef4e385eb65
https://doi.org/10.1016/j.jacep.2018.10.016
https://doi.org/10.1016/j.jacep.2018.10.016
Autor:
Gabriela V. Greenland, Maria Roselle Abraham, Prasanth Lingamaneni, Stefan L. Zimmerman, Celia P. Corona-Villalobos, Moumita Bhattacharya, Yufan Guan, Joseph E. Marine, Jeffrey E. Olgin, Hagit Shatkay, Theodore P. Abraham, Dai Yin Lu, Shibani M. Kudchadkar
Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HC) employs rules derived from American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD model (C-index
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::123e6cae63f1ebc2cde37b59a8d0af13
